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Abstract
Background: Although the standard tracheostomy described in 1909 by Jackson has been
extensively used in critical patients, a more simple procedure that can be performed at the
bedside is needed. Since 1957 several different types of percutaneous tracheostomy
technique have been described. The purpose of the present study was to compare two
bedside percutaneous tracheostomy techniques: percutaneous dilatational tracheostomy
(PDT) and the guidewire dilating forceps (GWDF).
Materials and methods: A prospective study in two medical/surgical intensive care units
(ICUs) was carried out. Sixty-three critically ill patients who required endotracheal intubation
for longer than 15 days were consecutively selected to undergo PDT (25 patients) or GWDF
(38 patients) technique. Intraoperative and postoperative complications were recorded.
Results: Age (mean±standard error) was 63±1.1 years. The patients had been
mechanically ventilated for an average of 19.8±1.2 days. The GWDF technique was
significantly faster than PDT technique (P=0.02). Fifteen complications occurred in 10 out of
63 (15%) patients. They were as follows: tracheal tear (one patient in each group; in one case
this was due to false passage); transient hypotension (one patient in the PDT group and two
patients in the GWDF group); atelectasis (one patient in the PDT group); and haemorrhage
(one patient in the PDT group and three patients in the GWDF group). In both patients with
tracheal tear, reduced arterial oxygen saturation (SaO2) with concomitant subcutaneous
emphysema ensued.
Conclusion: We found no statistical differences between complications with both
techniques. The surgical time required for the GWDF technique was less than that for PDT.
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Introduction
The standard tracheostomy technique described in 1909
by Jackson [1] has a complication rate of up to 66%
[2–7]. The most severely ill patients admitted to an ICU
often require a tracheostomy. A simple procedure, with a
lower rate of complications and that can be performed at
the bedside to eliminate the risk of transport to the operat-
ing room, is needed.
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Percutaneous tracheostomy was first described by
Shelden et al [8] in 1957. In 1969, Toy and Weinstein [9]
described a percutaneous tracheostomy system using the
guidewire approach of Seldinger. In 1985 Ciaglia et al
[10] described PDT, a method based on needle guidewire
airway access followed by serial dilatations with sequen-
tially larger dilators. In 1989, Schachner et al [11]
reported the Rapitrac (SurgiTech Medical, Sydney, Aus-
tralia), a dilating forceps device with a beveled metal cone
that is designed to advance forcibly over a wire into the
airway. Griggs et al [12] reported on the GWDF tech-
nique in 1990. This method is uses a forceps similar to the
that of the Rapitrac, except for the absence of a cutting
edge on the tip of the instrument.
The objective of the present study was to compare two
bedside tracheostomy systems, PDT and GWDF, in a pop-
ulation of critical care patients in two medical/surgical ICUs.
Materials and methods
A prospective study in two medical/surgical ICUs was
carried out over a 36-month period. Sixty-three critical
patients were consecutively selected to undergo PDT
(n = 25) or GWDF (n = 38) techniques. Patients who
required endotracheal intubation for more than 15 days
were included. Exclusion criteria were as follows: pres-
ence of any haemostatic defect (platelet count below
50 000/mm3, or activated partial thromboplastin time or
prothombin time greater than 1.5 × control); anatomic dis-
tortion of the trachea; previous neck surgery; goitre; and
any evidence of infection in the soft tissues of the neck.
Both techniques were performed with minimal variation
from their original descriptions [10,12]. All tracheostomies
were performed by the staff physicians of the ICU, and
only four intensivists (from a total of 14) were not previ-
ously skilled in these procedures. Tracheostomies per-
formed by the latter four intensivists were directly
supervised by experienced physicians, and all techniques
were done at the bedside of the patient.
The following data were recorded: age, sex, Acute Physi-
ology and Chronic Health Evaluation II score, fraction of
inspired oxygen (FIO2) before the tracheostomy, days in
mechanical ventilation before the tracheostomy, bleeding,
tracheal tear, subcutaneous emphysema, pneumothorax,
wound infection, hypotension, lowering SaO2 during the
procedure, inability to complete the procedure and proce-
dural mortality.
Complications were defined as follows: bleeding (a drop
in haematocrit level to below 3 points during the first 24 h
after the procedure); wound infection (cellulitis around the
stoma with purulent secretion, and microbiological tests in
this area documented); hypotension (mean arterial pres-
sure <60 mmHg); lowering of SaO2 during the procedure
(a drop to <90%); inability to complete the procedure
(when tracheostomy could not be performed with a
chosen technique and had to be done using conventional
technique or other percutaneous technique); subcuta-
neous emphysema, or pneumothorax documented by
chest radiograph; procedural mortality (mortality directly
related to a technique complication, during the procedure
or later during the stay in the ICU); tracheal tear (a tear
produced over tracheal wall during the procedure); and
false passage (dilatation or insertion of the cannula
outside the tracheal lumen).
Preparation of the patient
Patients were placed on a regimen of 1.0 FIO2, and anal-
gesia, sedation and relaxation were administered (midazo-
lam, fentanyl and pancuronium intravenously). The neck
was hyperextended and antiseptic solution on the surgical
field was administered. The endotracheal tube was reposi-
tioned above the site of the proposed tracheostomy. The
endotracheal tube cuff was deflated and it was withdrawn
to just below the vocal cords by an assistant. After that the
assistant held the tube with his or her hands continously
throughout the whole procedure. Blood pressure, cardiac
rhythm and arterial haemoglobin saturation were continu-
ously monitored throught the procedure. According to
their original descriptions [10,12], PDT and GWDF were
performed in the space between the cricoid and the first
tracheal cartilage or between the first and second tracheal
cartilages when it was possible.
Ciaglia technique was performed using the Ciaglia multi-
ple dilator kit (Ciaglia Percutaneous Tracheostomy Intro-
ducer Set; William Cook Europe, Bjaeverskov, Denmark).
Griggs technique was performed using the Percutaneous
Tracheostomy Kit (Portex Ltd, Hythe, Kent, UK).
Statistical analysis
Quantitative variables are described as mean±standard
error of the mean. Categorical variables are expressed as
percentages. Comparisons between means were done with
the Student’s t-test. Comparison between percentages
were performed with the χ2 test. Data were analyzed using
the Statistical Package for the Social Sciences Software
(version 7.5) for Windows (SPSS Inc, Chicago, IL, USA).
Results
Sixty-three patients were entered into the study, 25 for
PDT and 38 for GWDF. The mean age was 63 ± 1.1
years; 39 were men and 24 were women. The mean dura-
tion of translaryngeal intubation before the technique was
19.8 ± 1.2 days. The mean FIO2 before the technique was
0.47 ± 0.01. The mean Acute Physiology and Chronic
Health Evaluation (APACHE) II score was 21.6 ± 1.1.
Fourteen patients died in the ICU (22.2%), although none
of these deaths were related to technique complications.
Mortality in the ICU was higher in GWDF group, but this
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was not statistically significant (P = 0.09) and it was not
attributable to the procedure. Mean duration of the proce-
dure was significantly lower with the GWDF than with the
PDT technique (P = 0.02; Table 1).
The complications of the procedures were divided into
two categories: intraoperative and postoperative. Lower-
ing of SaO2, hypotension, tracheal tear and false passage
were considered intraoperative events. Emphysema,
atelectasis, haemorrhage, pneumothorax and wound infec-
tion were considered postoperative events. Intraoperative
and postoperative complications are showed in Table 2.
Three patients in the GWDF group developed bleeding,
as compared with only one patient in the PDT group (not
significant). Tracheal tear occurred in one patient from
each group. There were a total of 15 (23%) complications
in 10 (15%) patients, but there was no statistical differ-
ence between procedures.
Discussion
Of the different techniques for percutaneous tracheo-
stomy, PDT is the more widely used method in intensive
care medicine. Several studies [13–25] have been pub-
lished since its introduction, demonstrating the method to
be safe and cost-effective. Studies that compared PDT
with standard tracheostomy [26–29] demonstrated that
PDT was quicker, less traumatic, associated with fewer
early and late complications, and more cost-effective. Not
all studies that compared PDT with standard tracheo-
stomy demonstrated reduced complications, however
[30]. An increase in perioperative complications and mor-
tality was seen in studies that used Rapitrac [31], and in
studies in which the PDT was performed by physicians
who were inexperienced in the technique [32]. A meta-
analysis of studies to compare percutaneous versus surgi-
cal tracheostomy has been recently published [33].
Percutaneous tracheostomy was found to be associated
with a higher incidence of perioperative complications,
especially perioperative deaths and cardiorespiratory
arrests, but postoperative complication rates were found
to be higher with surgical tracheostomy. In that meta-
analysis, however, the authors do not take into account
the different techniques used, and that each technique
has its own method and complication rates [34].
Recently, Ambesh and Kaushik [35] compared PDT and
Rapitrach techniques in 80 patients (40 patients under-
went each technique) and they found no significant differ-
ences between the two methods. Powell et al [36],
however, in their review of the safety and efficacy of the
four methods of percutaneous tracheostomy, found a high
perioperative complication rate (22.9%) in nine series
using the Rapitrac technique. Those investigators found
only three series of patients who underwent the GWDF
technique (248 cases in total) and 29 series of patients
who underwent PDT (1074 cases is total). Only eight
complications (all haemorrhages) were reported with the
GWDF technique, three during the procedure and five
postoperatively. The PDT technique is the best studied,
and only one study was reported by the developer of the
technique [15], leaving 904 PDTs performed by other
investigators. Six deaths were reported for PDT. The peri-
operative complications of ‘blind’ (nonendoscopic) PDT
were 8.2%.
A limitation of our study was the sample size, which is too
small to allow definitive conclusions to be drawn, but we
believe that the present study makes a useful contribution.
Table 1
Demographic data between groups
Group
Variable PDT GWDF
n (%) 25 (39.7%) 38 (60.3%)
Age (years) 62.5 ± 2.3 62.7 ± 2.4
Male 14 (36%) 25 (64%)
APACHE II 23.5 ± 3.04 21 ± 1.2
Procedure duration (min) 25 ± 3.8* 17.3 ± 1.9
FIO2 before technique 0.47 ± 0.01 0.48 ± 0.02
Translaryngeal intubation time (days) 19.9 ± 1.8 19.7 ± 1.6
Mortality in ICU 3 (4.9%) 11 (18%)
Where applicable, values are expressed as mean ± standard error of
the mean. *P = 0.02, versus GWDF group.
Table 2
Procedure-related complications between PDT and GWDF
techniques
Group
Complication PDT GWDF Total
Intraoperative
Lowering of SaO2 1 1 2
Hypotension 1 2 3
Tracheal tear 1 1 2
False passage 0 1 1
Postoperative
Emphysema 1 1 2
Atelectasis 1 0 1
Haemorrhage 1 3 4
Pneumothorax 0 0 0
Wound infection 0 0 0
A few series with GWDF have been published, and only
one study, by Van Heerden et al [37], of 54 patients that
compared both techniques has been performed. They
used a bronchoscope for the first 15 cases and found that
bleeding and damage to the endotracheal tube were the
most common complications. They found no differences
between the two groups in terms of complications.
The present results show no statistical differences
between the two techniques. The complication rates
(9.6% with PDT technique and 14.6% with GWDF tech-
nique) are comparable to those of other series reported in
the literature using nonendoscopic PDT technique
[13,16,21–23,26]. Our procedural mortality was 0% and
there were no major complications such as tracheoinnomi-
nate fistula or mediastinitis. Only in one patient from each
group did a clinical important adverse event (tracheal tear)
occur. In the first patient a minimal anterior tracheal tear
with PDT due to a false passage occurred. A surgical
technique to repair it was performed. In the other patient,
tracheal tear resulted from use of the GWDF technique
and was probably due to the trachea characteristics of the
patient. In both cases concomitant subcutaneous emphy-
sema and lowering SaO2 were produced.
Hypotension was transient, and it was related only to the
administration of the anaesthesic agents. Haemorrhage
did not require surgical ligation, surgical exploration or
delay of the procedure. Only one patient needed blood
transfusion due to haemorrhage after the procedure. The
bleeding was stopped with conservative measures.
In three patients we were unable to complete the proce-
dure. The first case, with the PDT technique, this was due
to abnormal vasculature in the neck and we completed the
procedure using a standard tracheostomy. The other two
cases (with GWDF) were completed with PDT techique
because of inability to pass the tracheostomy tube
through the stoma. This was probably due to the design of
the obturator in the first version of the kit launched in
Spain. Once this obturator was replaced by an improved
one, the problem did not occur.
The notion of a percutaneous tracheostomy ‘learning
curve’ has been reported in the literature by several
authors [13,32,38,39] and should be emphasized. Petros
and Engelmann [24] documented an overall complication
rate of 11% with PDT, but the rate of acute complications
was 18.5% during the first 2 years and dropped to 6%
during the last 2 years, which they attributed to the ‘learn-
ing curve’. Our mean time for the procedure (with both
techiques) was higher than mean time reported by others
(4.3–15 min) [21,23–27], although the mean time
required to perform the GWDF technique was significantly
less than that required to perform the PDT technique. The
overall time ranged from 6 min when the technique was
performed by intensivists who were experienced with both
techniques, to 45 min when the physician who performed
the procedure had no previous experience. Also the tra-
cheal tear associated with false passage in a patient
described above could have been be due to this lack of
experience.
The more serious complication rates, such as false
passage or tracheal tear, could be improved with endo-
scopic guidance. Studies with PDT performed with endo-
scopic guidance [14,18,19,40,41] have reported lower
complication rates than studies performed with ‘blind’
PDT. Perioperative, postoperative and late complication
rates for endoscopic and nonendoscopic PDT have been
reported as follows: 7.2% versus 8.2%, 3.9% versus
6.1% and 1% versus 2.2%, respectively. The mortality
rates were 0.65% and 0.52%, respectively, for endoscopi-
cally guided and ‘blind’ PDT [36].
Differences between rates of complications can be due to
the lack of definition or homogeneity of complications. The
definition of haemorrhage differs between different
studies. Van Heurn et al [22] defined minor haemorrhage
as bleeding that lengthened the procedure and was con-
trolled by local compression, and major haemorrhage as
bleeding that required suture ligation; Petros and Engel-
mann [24] defined moderate stomal oozing as blood loss
of about 50–100 ml, whereas severe bleeding was
defined as a loss of more than 100 ml. Also, the definition
of wound infection differs between different studies. In the
present study, in accord with other authors [22], we
defined wound infection based on clinical and microbio-
logical criteria. In other papers, only clinical criteria were
recorded [19,26]. In other studies definitions of these
complications are lacking, and therefore their description
may be subjective [13,14,19,23,25,27,42].
We conclude that both techniques result in a safe place-
ment of a tracheostomy tube in the ICU. Although bleed-
ing was more common with GWDF, this was not
statistically significant and the higher mortality in this
group of patients was not related to the technique. The
mean duration of procedure was significantly lower with
GWDF than with PDT technique.
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